4//SEC Filing
Klassen Preston 4
Accession 0001209191-24-001779
CIK 0001505512other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 5:18 PM ET
Size
5.5 KB
Accession
0001209191-24-001779
Insider Transaction Report
Form 4
Klassen Preston
DirectorPresident & Head of R & D
Transactions
- Award
Stock Option (Right to Buy)
2024-01-12+120,000→ 120,000 totalExercise: $1.30Exp: 2034-01-11→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001493056
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 5:18 PM ET
- Size
- 5.5 KB